周五開播 | 從JPM大會，看新的一年行業走向( 二 ) _健康小知識

文章圖片
肖亮博士
LiangXiao,Ph.D
宜聯生物
MediLinkTherapeutics
聯合創始人
Co-founder
Dr.LiangXiao,cofounderofMediLinkTherapeutics(Suzhou)andhasservedasthecompany'schiefoperatingofficersinceMarch2021.Heismainlyresponsibleforantibodydiscovery,ADCevaluationandscreening,CMCandpreclinicalevaluation.
Dr.Xiaohas16yearsofexperienceinbiopharmaceuticalresearchinacademiaandindustry.Hehasbeenresponsibleforthediscovery,CMCandpreclinicalresearchofmultipleinnovativeantibodydrugs(includingmAbs,BsAbsandADCs).Amongthem,themostadvancedprogramhasfileBLAinChina,2ADCprogramsareunderPhIIIclinicaltrialsand2ADCprogramsareinPhIclinicaltrialsnow.Notably,multipleADCprogramshavereachedgloballicenseagreementwithMNC.
Dr.Xiaoreceivedhisbachelor'sdegreeinlifesciencefromtheUniversityofScienceandTechnologyofChinain2007andhisdoctor'sdegreeinchemicalengineeringfromtheUniversityofSouthernCaliforniain2013.

文章圖片
吳曉東博士
EricWu,Ph.D,MBA
鑫康合生物醫藥
KanovaBiopharma
商務運營副總裁
VicePresidentofBussinessDevelopment&Operations
17yearsofmedicalresearchandbusinessdevelopmentexperience.
DeepknowledgeofbothUSandChinahealthcareindustries.
DirectorofbusinessdevelopmentatReistoneBiopharma.
InternationalbusinessdevelopmentmanageratQilu-Pharma.
Ph.D.fromTexasA&MUniversity.
M.B.AfromNewYorkUniversity.

文章圖片
陳知瑋博士
KennethChen,Ph.D,MBA
柏思薈
bioSeedin
全球商務拓展經理
GlobalBDManager
Morethan12yearsofoverseadrugresearchanddiscoveryexperienceforautoimmunedisease.PreviouslyworkedasdrugdevelopmentresearchteamleaderattheNümbergHospitalimmunologyresearchcenter,Germany.ProjectmanagerinCRO.FunderofBioxix.BDandscientificconsultantforBioPharmadigitalmarketplacestartup.
Combinemultiplesmallmolecularandantibodydrugdevelopmentexperiencesfordifferenttypesofcancerandautoimmunedisease.Pre-INDprojectmanagementforMNCintheCRO.FundingBioxixtoprovidedrugdevelopmentanalysistechnologyandbigdataanalysisplatform.BioPharmamarketplacebusinessmodelconstruction,businessdevelopmentforMNCclients,andfurtherserviceplatformsetupandpenetration.Markingagoodcombinationofdrugdiscoveryexpertisetogetherwithbusinessdevelopmentexperience.

文章圖片
張藝林
PeterZhang,MBA,CFA
墾拓資本
CondenseCapital
投資總監
InvestmentDirector
Yearsofmedicalindustryexperiences,deepexpertiseinmedicalequipment,disposables,drugsandIVDmarketingandbusinessdevelopment.HaveservedsuccessivelyinAutobio,Novartis,B.BraunandFreseniusKabi.返回搜狐，查看更多
【周五開播 | 從JPM大會，看新的一年行業走向】責任編輯：

周五開播 | 從JPM大會，看新的一年行業走向( 二 )

周五開播 | 從JPM大會，看新的一年行業走向( 二 )